Liver sinusoidal endothelial cell defenestration in chronic heart failure is primarily dependent on cardiac diastolic dysfunction and is reversed by a sodium-glucose cotransporter 2 inhibitor but not by an angiotensin-converting enzyme inhibitor
Authors:
- Kamila Wojnar-LasonKWKamila Wojnar-Lason
- Marta StojakMSMarta Stojak
- Grzegorz KwiatkowskiGKGrzegorz Kwiatkowski
- Magdalena GiergielMGMagdalena Giergiel
- Anna KurpinskaAKAnna Kurpinska
- Urszula TyrankiewiczUTUrszula Tyrankiewicz
- Marta Z PaciaMarta Z Pacia
- Agnieszka KijAKAgnieszka Kij
- Magdalena SternakMSMagdalena Sternak
- Michal PaciaMPMichal Pacia
- Marek GrosickiMGMarek Grosicki
- Joanna ZemlaJZJoanna Zemla
Open Access
- 11 August 2026
- journal article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 122 (14) , 1992-2008
Abstract
Aims: Liver sinusoidal endothelial cells (LSECs) dysfunction was demonstrated to represent an early and persistent event in chronic heart failure (CHF), preceding congestive hepatopathy and contributing to the pathophysiology of the disease. However, it remains unknown whether classical CHF pharmacotherapy would reverse LSEC defenestration. Herein, we characterized the therapeutic effects of angiotensin-converting enzyme inhibitor (ACE-I)—perindopril—and sodium-glucose cotransporter 2 inhibitor (SGLT2-I)—empagliflozin—on the cardiohepatic axis and, in particular, on LSEC defenestration in the murine model of CHF. Methods and results: Untreated 6-month-old Tgαq*44 mice exhibited impaired systolic and diastolic cardiac function, impaired liver perfusion, and LSEC defenestration. Perindopril (2 mg/kg, 8 weeks of treatment, 4- to 6-month-old Tgαq*44 mice) significantly improved the left ventricular (LV) and right ventricular (RV) systolic function and ameliorated liver perfusion in vivo in Tgαq*44 mice. Perindopril also displayed a pronounced hepatoprotective effect, as evidenced by proteomic analysis of isolated hepatocytes, reduced total bilirubin, and gamma-glutamyltransferase; however, the number of LSEC fenestrations was unaffected in Tgαq*44 mice treated with perindopril. Empagliflozin (300 mg/kg, 8 weeks of treatment, 4- to 6-month-old Tgαq*44 mice) not only significantly improved LV and RV systolic function and ameliorated liver perfusion but also improved diastolic cardiac function and significantly reduced the defenestration of LSECs. Conclusion: LSEC defenestration was primarily driven by cardiac diastolic dysfunction, not by impaired liver perfusion or hepatocyte function, and was independent of biomarkers of congestive hepatopathy in the murine model of CHF in Tgαq*44 mice. As fully reversed by SGLT2-I, but not by ACE-I, LSEC defenestration emerges as a target in the treatment of the cardiohepatic axis in CHF, which is not uniformly improved by CHF pharmacotherapy.Keywords
Funding Information
- Narodowym Centrum Nauki
- PRELUDIUM (2019/35/N/NZ5/03568)
- PRELUDIUM (K.W-L)
- MAESTRO (2021/42/A/NZ4/00273)
- MAESTRO (S.C)
- SONATA (2021/43/D/ST4/02311)
- SONATA (M.Z.P)
- SONATA (2019/35/D/NZ3/01804)
- SONATA (B.Z)
This publication has 71 references indexed in Scilit:
- SGLT2 Inhibitors for the Prevention and Treatment of Heart Failure: A Scientific Statement of the HFA and the HFAIESC Heart Failure, 2025
- Angiotensin‐converting enzyme inhibitors prevent liver‐related events in nonalcoholic fatty liver diseaseHepatology, 2021
- Sphingosine‐1‐phosphate promotes tumor development and liver fibrosis in mouse model of congestive hepatopathyHepatology, 2021
- Tracking Fenestrae Dynamics in Live Murine Liver Sinusoidal Endothelial CellsHepatology, 2019
- Right Heart Dysfunction and Failure in Heart Failure with Preserved Ejection Fraction: Mechanisms and Management. Position Statement on Behalf of the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure, 2017
- Chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis and mechanical forcesHepatology, 2014
- Dilated Cardiomyopathy in Two Transgenic Mouse Lines Expressing Activated G Protein αq: Lack of Correlation Between Phospholipase C Activation and the PhenotypeJournal of Molecular and Cellular Cardiology, 2001
- Defenestration of the sinusoidal endothelial cell in a rat model of cirrhosisHepatology, 1993
- Liver Function Abnormalities in Chronic Heart FailureArchives of internal medicine (1960), 1987
- Alcoholic liver injury: Defenestration in noncirrhotic livers—a scanning electron microscopic studyHepatology, 1987